About this trial
This is a prospective, observational study designed to describe disease progression, symptom change, quality of life, diet and lifestyle habits, and frequency of adverse events among patients with multiple sclerosis (MS) who use complementary and alternative medicine (CAM). In addition to describing the patterns of CAM use, this study will also identify and describe the positive deviants, those individuals with the highest quality of life and least amount of disease activity. Positive deviants will be compared to controls in order to describe medication, diet, and lifestyle patterns associated with a lack of MS disease progression and high quality of life.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of multiple sclerosis (including relapsing remitting MS, secondary progressive MS, primary progressive MS, clinically isolated syndromes (CIS), radiologically-isolated syndromes (RIS), possible MS, or probable MS.
Age 18-100
Disqualifiers
Inability to read/write in English
Inability or unwillingness to complete surveys every six (6) months. (~ 90 min)
Trial population
Any individual with multiple sclerosis is invited to participate.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
"CAM Therapies" survey
This survey has been developed to identify the complementary and alternative therapies most commonly used by individuals with MS. Results will be reported with descriptive statistics.
Secondary outcomes
Modified Expanded Disability Severity Score (EDSS)
The EDSS will be used to capture disease severity and rates of progression in this cohort.
Other outcomes
PROMIS: Global Health
This outcome measure will be used to assess general health and well-being in this CAM using cohort.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.